418 related articles for article (PubMed ID: 26635315)
1. Nosocomial Acinetobacter pneumonia: Treatment and prognostic factors in 356 cases.
Özvatan T; Akalın H; Sınırtaş M; Ocakoğlu G; Yılmaz E; Heper Y; Kelebek N; İşçimen R; Kahveci F
Respirology; 2016 Feb; 21(2):363-9. PubMed ID: 26635315
[TBL] [Abstract][Full Text] [Related]
2. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
[TBL] [Abstract][Full Text] [Related]
3. [Nosocomial pneumonia due to Acinetobacter baumannii].
Cisneros-Herreros JM; Garnacho-Montero J; Pachón-Ibáñez ME
Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():46-51. PubMed ID: 16854341
[TBL] [Abstract][Full Text] [Related]
4. Acinetobacter baumannii ventilator-associated pneumonia: epidemiological and clinical findings.
Garnacho-Montero J; Ortiz-Leyba C; Fernández-Hinojosa E; Aldabó-Pallás T; Cayuela A; Marquez-Vácaro JA; Garcia-Curiel A; Jiménez-Jiménez FJ
Intensive Care Med; 2005 May; 31(5):649-55. PubMed ID: 15785929
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
6. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
[TBL] [Abstract][Full Text] [Related]
7. Colistin-tigecycline versus colistin-imipenem-cilastatin combinations for the treatment of Acinetobacter baumannii ventilator-acquired pneumonia: a prognosis study.
Chaari A; Pham T; Mnif B; Chtara K; Medhioub F; Baccouche N; Bahloul M; Hammami A; Bouaziz M
Intensive Care Med; 2015 Nov; 41(11):2018-9. PubMed ID: 26264246
[No Abstract] [Full Text] [Related]
8. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality.
Li YJ; Pan CZ; Fang CQ; Zhao ZX; Chen HL; Guo PH; Zhao ZW
BMC Infect Dis; 2017 May; 17(1):371. PubMed ID: 28558660
[TBL] [Abstract][Full Text] [Related]
9. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
11. Acinetobacter baumannii nosocomial pneumonia: is the outcome more favorable in non-ventilated than ventilated patients?
Yang YS; Lee YT; Huang TW; Sun JR; Kuo SC; Yang CH; Chen TL; Lin JC; Fung CP; Chang FY
BMC Infect Dis; 2013 Mar; 13():142. PubMed ID: 23509931
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Zheng YL; Wan YF; Zhou LY; Ye ML; Liu S; Xu CQ; He YQ; Chen JH
Am J Infect Control; 2013 Jul; 41(7):e59-63. PubMed ID: 23523521
[TBL] [Abstract][Full Text] [Related]
13. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
14. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Dizbay M; Tunccan OG; Sezer BE; Hizel K
Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
[TBL] [Abstract][Full Text] [Related]
15. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
Demirdal T; Sari US; Nemli SA
Ann Clin Microbiol Antimicrob; 2016 Feb; 15():11. PubMed ID: 26911714
[TBL] [Abstract][Full Text] [Related]
16. Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Lin HS; Lee MH; Cheng CW; Hsu PC; Leu HS; Huang CT; Ye JJ
Infect Dis (Lond); 2015 Jun; 47(6):370-8. PubMed ID: 25746600
[TBL] [Abstract][Full Text] [Related]
17. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii.
Chusri S; Chongsuvivatwong V; Rivera JI; Silpapojakul K; Singkhamanan K; McNeil E; Doi Y
Antimicrob Agents Chemother; 2014 Jul; 58(7):4172-9. PubMed ID: 24820079
[TBL] [Abstract][Full Text] [Related]
19. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
Arnold HM; Sawyer AM; Kollef MH
Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
[TBL] [Abstract][Full Text] [Related]
20. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
